Recent studies of breast cancer tissue samples demonstrated that CX3CL1 expression correlates with increased anti-tumor immune cells, including CD8+ T cells, NK cells and Cd1a+ dendritic cells, which correlated with better patient prognosis [50]. This evidence concerns the gene CX3CL1 and neoplasm.